Patents by Inventor Hsuan-Ang Tsai

Hsuan-Ang Tsai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of cycloserine compounds and applications thereof
    Patent number: 11291654
    Abstract: Formulations comprising cycloserine compounds and one or more enteric materials in a solid dosage form, and uses thereof for treating and/or reducing the risk of a neuropsychiatric disorder or tuberculosis.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: April 5, 2022
    Assignee: SyneuRx International (Taiwan) Corp.
    Inventors: Guochuan Emil Tsai, Ching-Cheng Wang, Hsin-Hsin Yang, Hsuan-Ang Tsai
  • FORMULATIONS OF CYCLOSERINE COMPOUNDS AND APPLICATIONS THEREOF
    Publication number: 20220047560
    Abstract: A solid dosage form comprises an inner core containing a cycloserine compound and an outer layer attached to the inner core. The dosage form can be enteric tablet or transdermal patch, suitable for treating a neuropsychiatric disorder or tuberculosis.
    Type: Application
    Filed: September 12, 2019
    Publication date: February 17, 2022
    Applicant: SyneuRx International (Taiwan) Corp.
    Inventors: Guochuan Emil Tsai, Chih-Chien Wang, Hsin-Hsin Yang, Hsuan-Ang Tsai
  • FORMULATIONS OF CYCLOSERINE COMPOUNDS AND APPLICATIONS THEREOF
    Publication number: 20200085792
    Abstract: Formulations comprising cycloserine compounds and one or more enteric materials in a solid dosage form, and uses thereof for treating and/or reducing the risk of a neuropsychiatric disorder or tuberculosis.
    Type: Application
    Filed: September 13, 2018
    Publication date: March 19, 2020
    Applicant: SyneuRx International (Taiwan) Corp.
    Inventors: Guochuan Emil Tsai, Ching-Cheng Wang, Hsin-Hsin Yang, Hsuan-Ang Tsai